Us Congress 2023-2024 Regular Session

Us Congress House of Representatives 2023 Bills & Legislation (Page 87)

US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB1659

Introduced
3/17/23  
Refer
3/17/23  
Department of Veterans Affairs IT Modernization Improvement Act of 2023
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB166

Introduced
1/9/23  
Fair Lending for All Act This bill modifies provisions related to prohibited credit discrimination. The bill adds sexual orientation, gender identity, and an applicant's location based on zip code or census tract as classes protected against discrimination with respect to credit transactions. (Currently, discrimination is prohibited on the basis of race, color, religion, national origin, sex, marital status, age, or because an applicant receives public assistance.) The bill establishes criminal penalties for violations of prohibited credit discrimination. The Consumer Financial Protection Bureau is required to review loan applications for compliance with specified consumer laws and to establish an Office of Fair Lending Testing.
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB1660

Introduced
3/17/23  
Refer
3/17/23  
Avi Kwa Ame National Monument Establishment Act of 2023
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB1661

Introduced
3/17/23  
Discriminatory Gaming Tax Repeal Act of 2023
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB1662

Introduced
3/17/23  
Emergency Liquidity Act of 2023
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB1663

Introduced
3/17/23  
Critical Bank Review Act
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB1664

Introduced
3/17/23  
Financial Stability Mandate Act
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB1665

Introduced
3/17/23  
Refer
3/17/23  
Refer
3/20/23  
Safe Charging Electrical Bikes and Scooters Act
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB1666

Introduced
3/17/23  
Refer
3/17/23  
Protecting Access to Ground Ambulance Medical Services Act of 2023
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB1667

Introduced
3/17/23  
Refer
3/17/23  
Ouachita National Forest Overnight Camping Act
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB1668

Introduced
3/21/23  
Refer
3/21/23  
Sarah Debbink Langenkamp Active Transportation Safety Act
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB1669

Introduced
3/21/23  
Refer
3/21/23  
Refer
4/11/23  
Report Pass
4/28/23  
VET–TEC Authorization Act of 2023
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB167

Introduced
1/9/23  
Refer
1/9/23  
Patient Access to Urgent-Use Pharmacy Compounding Act of 2023 This bill relaxes certain requirements for compounding drugs that are facing shortages. Drug compounding is the process of mixing or otherwise altering drugs to create a medication. Currently, the Food and Drug Administration (FDA) allows for drug compounding subject to certain requirements. Generally, a licensed pharmacist or physician not registered with the FDA may only compound drugs in limited quantities for prescriptions for a specific individual patient. On the other hand, an FDA-registered outsourcing facility may compound drugs in bulk for use in medical facilities but is subject to additional requirements. This bill allows a compounder not registered with the FDA to compound drugs in limited quantities for an urgent medical need not involving a specific patient if, among other requirements (1) the prescriber certifies that the prescriber is unable, despite reasonable attempts, to obtain certain related drugs with the same active ingredient and route of administration; (2) the compounded drug meets certain labeling requirements, including an indication that the compounded drug is provided only for urgent administration to a patient; and (3) the compounder requests and maintains certain records about patients receiving the compounded drug. Furthermore, a restriction against an unregistered compounder regularly compounding (or compounding inordinate amounts of) what is essentially a copy of a commercially available drug shall not apply if the drug is on a shortage list maintained by the FDA or the American Society of Hospital Pharmacists.
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB1670

Introduced
3/21/23  
Refer
3/21/23  
MATCH Act of 2023 Making Access To Cleanup Happen Act of 2023
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB1671

Introduced
3/21/23  
Refer
3/21/23  
Increasing Access to Dental Insurance Act

Research Filters

States
Terms / Sessions
Chamber Records